Johnson Investment Counsel’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-942
Closed -$257K 825
2025
Q4
$257K Sell
942
-472
-33% -$128K ﹤0.01% 713
2025
Q3
$382K Buy
1,414
+366
+35% +$99.6K ﹤0.01% 639
2025
Q2
$289K Buy
+1,048
New +$285K ﹤0.01% 678
2023
Q3
Sell
-1,115
Closed -$207K 688
2023
Q2
$207K Buy
1,115
+15
+1% +$2.77K ﹤0.01% 634
2023
Q1
$211K Buy
+1,100
New +$199K ﹤0.01% 616
2022
Q4
Sell
-1,245
Closed -$221K 665
2022
Q3
$221K Buy
1,245
+94
+8% +$18.6K ﹤0.01% 593
2022
Q2
$236K Buy
+1,151
New +$244K ﹤0.01% 583
2020
Q1
Sell
-1,063
Closed -$216K 549
2019
Q4
$216K Sell
1,063
-160
-13% -$32.8K ﹤0.01% 560
2019
Q3
$258K Buy
+1,223
New +$256K 0.01% 526

Other funds holding CME

Johnson Investment Counsel's CME Position: Q1 2026 in Review

Johnson Investment Counsel sold out of CME Group (CME) in Q1 2026, closing a stake of 942 shares — an estimated $257K sold.

Johnson Investment Counsel first reported a position in CME in Q3 2019 and held it in 9 quarters. The position peaked at $382K in Q3 2025. 1,801 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Johnson Investment Counsel reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
  • Johnson Investment Counsel sold 942 CME Group shares in Q1 2026, an estimated $257K.
  • Johnson Investment Counsel first reported a position in CME Group in Q3 2019 and held it in 9 quarters.
  • Johnson Investment Counsel's CME Group position peaked at $382K in Q3 2025.
  • 1,801 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Johnson Investment Counsel's 13F filing for Q1 2026, filed 4 May 2026.